2024
Hare L, Trotman J, Tarpey P, Hook E, Burke GAA. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a DDX3X::MLLT10 fusion and an IGH deletion. Pediatr Blood Cancer. 2024; 71:e30810. https://doi.org/10.1002/pbc.30810 (opens in a new tab)
2023
Chadda, K. R., Solano-Páez, P., Khan, S., Llempén-López, M., Phyu, P., Horan, G., Trotman, J., Tarpey, P., Erker, C., Lindsay, H., Addy, D., Jacques, T. S., Allinson, K., Pizer, B., Huang, A., & Murray, M. J. (2023). Embryonal tumor with multilayered rosettes: Overview of diagnosis and therapy. Neuro-oncology advances, 5(1), vdad052. https://doi.org/10.1093/noajnl/vdad052 (opens in a new tab)
Green, R., Ahmed, A., Fleming, B., Long, A. M., Behjati, S., Trotman, J., Tarpey, P., Nicholson, J. C., Coleman, N., Elizabeth Hook, C., & Murray, M. J. (2023). Wilms Tumor With Raised Serum Alpha-Fetoprotein: Highlighting the Need for Novel Circulating Biomarkers. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 10935266231213467. Advance online publication. https://doi.org/10.1177/10935266231213467 (opens in a new tab)
Watkins, J. A., Hatcher, H., Malhotra, S., Amen, F., Bruty, J., Trotman, J., Tarpey, P., & Tadross, J. A. (2023). Identification of an Activating PDGFRA Deletion in a Novel Sinonasal Soft Tissue Neoplasm. Head and neck pathology, 10.1007/s12105-023-01526-0. Advance online publication. https://doi.org/10.1007/s12105-023-01526-0 (opens in a new tab)
Mavaddat, N., Ficorella, L., Carver, T., Lee, A., Cunningham, A. P., Lush, M., Dennis, J., Tischkowitz, M., Downes, K., Hu, D., Hahnen, E., Schmutzler, R. K., Stockley, T. L., Downs, G. S., Zhang, T., Chiarelli, A. M., Bojesen, S. E., Liu, C., Chung, W. K., Pardo, M., … Easton, D. F. (2023). Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, EPI-22-0756. Advance online publication. https://doi.org/10.1158/1055-9965.EPI-22-0756 (opens in a new tab)
De Noon, S., Piggott, R., Trotman, J., Tadross, J. A., Fittall, M., Hughes, D., Ye, H., Munasinghe, E., Murray, M., Tirabosco, R., Amary, F., Coleman, N., Watkins, J., Hubank, M., Tarpey, P., Behjati, S., & Flanagan, A. M. (2023). Recurrent FOSL1 rearrangements in desmoplastic fibroblastoma. The Journal of pathology, 259(2), 119–124. https://doi.org/10.1002/path.6038 (opens in a new tab)
2022
Ellingford, J. M., Ahn, J. W., Bagnall, R. D., Baralle, D., Barton, S., Campbell, C., Downes, K., Ellard, S., Duff-Farrier, C., FitzPatrick, D. R., Greally, J. M., Ingles, J., Krishnan, N., Lord, J., Martin, H. C., Newman, W. G., O'Donnell-Luria, A., Ramsden, S. C., Rehm, H. L., Richardson, E., … Whiffin, N. (2022). Recommendations for clinical interpretation of variants found in non-coding regions of the genome. Genome medicine, 14(1), 73.
Archer, S., Fennell, N., Colvin, E., Laquindanum, R., Mills, M., Dennis, R., Stutzin Donoso, F., Gold, R., Fan, A., Downes, K., Ford, J., Antoniou, A. C., Kurian, A. W., Evans, D. G., & Tischkowitz, M. (2022). Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial. Cancers, 14(11), 2716.
Briggs, M., Das, A., Firth, H., Levine, A., Sánchez-Ramírez, S., Negm, L., Ercan, A. B., Chung, J., Bianchi, V., Jalloh, I., Phyu, P., Thorp, N., Grundy, R. G., Hawkins, C., Trotman, J., Tarpey, P., Tabori, U., Allinson, K., Murray, M. J., & Genomics England Research Consortium (2022). Recurrent posterior fossa group A (PFA) ependymoma in a young child with constitutional mismatch repair deficiency (CMMRD). Neuropathology and applied neurobiology, e12862. Advance online publication.https://doi.org/10.1111/nan.12862 (opens in a new tab)
Zhao, Y., Gardner, E. J., Tuke, M. A., Zhang, H., Pietzner, M., Koprulu, M., Jia, R. Y., Ruth, K. S., Wood, A. R., Beaumont, R. N., Tyrrell, J., Jones, S. E., Lango Allen, H., Day, F. R., Langenberg, C., Frayling, T. M., Weedon, M. N., Perry, J., Ong, K. K., & Murray, A. (2022). Detection and characterization of male sex chromosome abnormalities in the UK Biobank study. Genetics in medicine : official journal of the American College of Medical Genetics, S1098-3600(22)00777-8. Advance online publication. https://doi.org/10.1016/j.gim.2022.05.011 (opens in a new tab)
French, C. E., Dolling, H., Mégy, K., Sanchis-Juan, A., Kumar, A., Delon, I., Wakeling, M., Mallin, L., Agrawal, S., Austin, T., Walston, F., Park, S. M., Parker, A., Piyasena, C., Bradbury, K., Next Generation Children’s Project Consortium, Ellard, S., Rowitch, D. H., & Raymond, F. L. (2022). Refinements and considerations for trio whole-genome sequence analysis when investigating Mendelian diseases presenting in early childhood. HGG advances, 3(3), 100113. https://doi.org/10.1016/j.xhgg.2022.100113 (opens in a new tab)
Trotman, J., Armstrong, R., Firth, H. Firth, H., Trayers, C., Watkins, J., Allinson, K., Jacques, T.S., Nicholson, J.C., Burke, G.A.A., Genomics England Research Consortium, Behjati, S., Murray, M.J., Hook, C.E., Tarpey, P. The NHS England 100,000 Genomes Project: feasibility and utility of centralised genome sequencing for children with cancer. Br J Cancer (2022). https://doi.org/10.1038/s41416-022-01788-5 (opens in a new tab)
Sagi, S. V., Joshi, H., Trotman, J., Elsey, T., Swamy, A., Rajkanna, J., Bhat, N. A., Haddadin, F., Oyibo, S. O., & Park, S. M. (2020). A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism. Endocrinology, diabetes & metabolism case reports, 2020, 20-0084. Advance online publication. https://doi.org/10.1530/EDM-20-0084 (opens in a new tab)
Truelove, A., Mulay, A., Prapa, M., Casey, R. T., Adler, A. I., Offiah, A. C., Poole, K., Trotman, J., Al Hasso, N., & Park, S. M. (2019). Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders. American journal of medical genetics. Part A, 179(7), 1330–1337. https://doi.org/10.1002/ajmg.a.61163 (opens in a new tab)
Garrett, A., Loveday, C., King, L., Butler, S., Robinson, R., Horton, C., Yussuf, A., Choi, S., Torr, B., Durkie, M., Burghel, G. J., Drummond, J., Berry, I., Wallace, A., Callaway, A., Eccles, D., Tischkowitz, M., Tatton-Brown, K., Snape, K., McVeigh, T., … Cancer Variant Interpretation Group UK (CanVIG-UK) (2022). Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD. Genetics in medicine : official journal of the American College of Medical Genetics, 24(1), 41–50. https://doi.org/10.1016/j.gim.2021.08.004 (opens in a new tab)
MMR: CanVIG-UK Gene-Specific Guidance. Date: 05/01/2022 Version: 1.4. A Garrett , L Loong , L King , M Durkie, J. Drummond , G.J. Burghel , R. Robinson , A Callaway, I. Berry, A. Wallace , E. Woodward, G. Evans, H. Hanson, C.Turnbull (https://www.cangene-canvaruk.org/gene-specific-recommendations)